Treatment of rheumatoid Arthritis in Practice - a Comparison of Tocilizumab vs. TNF-Inhibitors (CONSENS)

被引：0
|
作者：
Backhaus, M. [1 ]
Kaufmann, J.
Richter, C.
Vollmer, M.
Volberg, C. [2 ]
Wassenberg, S. [3 ]
Roske, A. [4 ]
Hellmann, P. [5 ]
Gaubitz, M. [6 ]
机构：
[1] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-13353 Berlin, Germany
[2] Rheumazentrum Neuss, Neuss, Germany
[3] Evangel Fachkrankenhaus, Rheumazentrum Ratingen, Rheumatol Klin, Ratingen, Germany
[4] Roche Pharma AG, Grenzach Wyhlen, Germany
[5] Chugai Pharma Mkt Ltd, Frankfurt, Germany
[6] WWU Munster, Akad Manuelle Therapie, Munster, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [1] A cost-efficacy comparison of TNF-inhibitors in the treatment of rheumatoid arthritis
    Chiou, C
    Malone, DC
    Wanke, LA
    Yu, EB
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 269 - 269
  • [2] B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V.
    Martins, N.
    Canhao, H.
    Fonseca, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 905 - 905
  • [3] B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V.
    Martins, N.
    Canhao, H.
    Fonseca, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A5 - A5
  • [4] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [5] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Ingrid Lekander
    Fredrik Borgström
    Jörgen Lysholm
    Ronald F. van Vollenhoven
    Staffan Lindblad
    Pierre Geborek
    Gisela Kobelt
    [J]. The European Journal of Health Economics, 2013, 14 : 863 - 873
  • [6] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Lekander, Ingrid
    Borgstrom, Fredrik
    Lysholm, Jorgen
    van Vollenhoven, Ronald F.
    Lindblad, Staffan
    Geborek, Pierre
    Kobelt, Gisela
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 863 - 873
  • [7] SERIOUS INFECTION WITH TOCILIZUMAB COMPARED TO TNF-INHIBITORS AND OTHER BDMARDS IN RHEUMATOID ARTHRITIS PATIENTS: DOES LINE OF THERAPY MATTER?
    Lauper, K.
    Kearsley-Fleet, L.
    Davies, R.
    Watson, K.
    Lunt, M.
    Hyrich, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 148 - 148
  • [8] B-CELL PHENOTYPE AND IGD-CD27-MEMORY B CELLS ARE AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, Rita A.
    Quaresma, Claudia
    Vieira, Ana R.
    Goncalves, Maria J.
    Polido-Pereira, Joaquim
    Romao, Vasco C.
    Martins, Nadia
    Canhao, Helena
    Fonseca, Joao E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A3 - A3
  • [9] SERUM ADIPOKINES PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF-INHIBITORS
    Novella-Navarro, M.
    Hernandez-Breijo, B.
    Genre, F.
    Lera-Gomez, L.
    Pulito-Cueto, V.
    Nuno, L.
    Villalba, A.
    Balsa, A.
    Plasencia, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 972 - 972
  • [10] SERIOUS INFECTION WITH TOCILIZUMAB COMPARED TO TNF-INHIBITORS AND OTHER BDMARDS IN RHEUMATOID ARTHRITIS PATIENTS: DOES LINE OF THERAPY MATTER?
    Lauper, Kim
    Kearsley-Fleet, Lianne
    Davies, Rebecca
    Watson, Kath
    Lunt, Mark
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2021, 60
12345